FDA offers draft guidance for registries as RWD
Regulatory NewsMary Ellen Schneider
BiologicsClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderBiologicsClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy